LEADER 01540nam  2200397Ia 450 
001 9910698829303321
005 20090527145612.0
035   $a(CKB)5470000002397575
035   $a(OCoLC)352919521
035   $a(EXLCZ)995470000002397575
100   $a20090527d2002      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $evalidation of procedures for processing of human tissues intended for transplantation
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,$d[2002]
215   $a3 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on May 27, 2009).
300   $a"Final guidance".
300   $a"March 2002".
517   $aGuidance for industry 
606   $aTissue banks$xGovernment policy$zUnited States
606   $aTransplantation of organs, tissues, etc$xGovernment policy$zUnited States
606   $aMicrobial contamination$zUnited States$xPrevention
615  0$aTissue banks$xGovernment policy
615  0$aTransplantation of organs, tissues, etc.$xGovernment policy
615  0$aMicrobial contamination$xPrevention.
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698829303321
996   $aGuidance for industry$93434577
997   $aUNINA